TNBC is characterized as estrogen receptor (ER) negative, progesterone receptor (PR) negative, and human epidermal growth factor receptor 2 (HER2) negative, while these receptors are commonly expressed in other subtypes of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.